The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than anything currently on the market.
Source: US Top News and Analysis
Related Posts
‘All bets are off’: European borrowing costs hit 15-year highs as investors brace for rate hikes
Bonds issued by various European countries continued to sell off on Friday, deepening a rout…
Use options to play a potential Invesco runup in wake of Janus Henderson deal
Asset managers are trading at a significant discount to the broad market. Source: US Top…
Senate, White House start to coalesce around ending DHS shutdown amid TSA delays
The Department of Homeland Security has been shut down since February over Democratic concerns about…